In this study, decreased expression of p-AKT and Nrf2 proteins was observed with disease progression, suggesting that during early-stage diabetic nephropathy, the body consumes endogenous Nrf2 signaling to enhance antioxidant protein expression, thereby boosting antioxidant capacity and mitigating oxidative damage. The gene discussed is AKT1; the disease is diabetic kidney disease.